Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
22 hedge funds and large institutions have $5.69M invested in Biocept, Inc. in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
22% more funds holding
Funds holding: 18 → 22 (+4)
18% more capital invested
Capital invested by funds: $4.83M → $5.69M (+$858K)
1.38% more ownership
Funds ownership: 8.18% → 9.57% (+1.4%)
24% less call options, than puts
Call options by funds: $160K | Put options by funds: $211K
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$528K |
| 2 |
Morgan Stanley
New York
|
+$230K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$150K |
| 4 |
Man Group
London,
United Kingdom
|
+$78.8K |
| 5 |
Bank of New York Mellon
New York
|
+$77.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
-$380K |
| 2 |
Renaissance Technologies
New York
|
-$48K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$14.3K |
| 4 |
JP Morgan Chase
New York
|
-$13K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$5.7K |
BIOC Hedge Fund Activity: Q4 2020 in Review
22 of the 5,677 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q4 2020, worth a combined $5.69M — up 18% from $4.83M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new BIOC positions and 4 closed out — a net gain of 4 holders — while 3 added to existing stakes and 5 trimmed.
The largest buyer was Driehaus Capital Management, opening a new position worth an estimated $528K. The largest seller was Hussman Strategic Advisors, cutting an estimated $380K.
- 22 institutional investors held Biocept, Inc. (BIOC) as of Q4 2020, up from 18 in Q3 2020.
- Funds reported $5.69M of Biocept, Inc. stock for Q4 2020, up 18% quarter-over-quarter.
- 8 funds opened new Biocept, Inc. positions in Q4 2020 and 4 closed out, a net change of +4 holders.
- The largest Biocept, Inc. buyer in Q4 2020 was Driehaus Capital Management, an estimated $528K added.
- The largest Biocept, Inc. seller in Q4 2020 was Hussman Strategic Advisors, an estimated $380K sold.
Based on aggregated 13F filings for Q4 2020.